These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5565 related articles for article (PubMed ID: 4005832)

  • 1. Effect of dimethyldioctadecylammonium bromide induced macrophages on malignant cell proliferation.
    Prager MD; Kanar MC; Farmer JL; Vanderzee J
    Cancer Lett; 1985 Jun; 27(2):225-32. PubMed ID: 4005832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired macrophage functions as a possible basis of immunomodification by microbial agents, tilorone and dimethyldioctadecylammonium bromide.
    Bloksma N; de Reuver MJ; Willers JM
    Antonie Van Leeuwenhoek; 1983 Apr; 49(1):13-22. PubMed ID: 6351737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of antigens with dimethyldioctadecylammonium bromide, a chemically defined biological response modifier.
    Baechtel FS; Prager MD
    Cancer Res; 1982 Dec; 42(12):4959-63. PubMed ID: 7139599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of enhanced resistance against Listeria monocytogenes induced with ribosomal RNA and the adjuvant dimethyldioctadecylammonium bromide.
    Antonissen AC; Lemmens PJ; van den Bosch JF; van Boven CP
    Immunol Lett; 1986 Nov; 14(1):21-8. PubMed ID: 3804382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.
    van den Bosch JF; Kanis IY; Antonissen AC; Buurman WA; van Boven CP
    Infect Immun; 1986 Sep; 53(3):611-5. PubMed ID: 3091505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro macrophage activation by systemic adjuvants.
    Bruley-Rosset M; Florentin I; Mathé G
    Agents Actions; 1976 Feb; 6(1-3):251-5. PubMed ID: 782207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin.
    Chang ZL; Bonvini E; Varesio L; Holden HT; Herberman RB
    Cell Immunol; 1988 Jul; 114(2):282-92. PubMed ID: 2839302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial resistance, macrophage influx, and activation induced by bacterial rRNA with dimethyldioctadecylammonium bromide.
    Gonggrijp R; Mullers WJ; Dullens HF; van Boven CP
    Infect Immun; 1985 Dec; 50(3):728-33. PubMed ID: 2415454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.
    Hussain MJ; Wilkinson A; Bramwell VW; Christensen D; Perrie Y
    J Pharm Pharmacol; 2014 Mar; 66(3):358-66. PubMed ID: 24251796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
    Hanyecz A; Berlo SE; Szántó S; Broeren CP; Mikecz K; Glant TT
    Arthritis Rheum; 2004 May; 50(5):1665-76. PubMed ID: 15146438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model.
    Wang YQ; Zhang HH; Liu CL; Wu H; Wang P; Xia Q; Zhang LX; Li B; Wu JX; Yu B; Gu TJ; Yu XH; Kong W
    Int Immunopharmacol; 2013 Sep; 17(1):9-17. PubMed ID: 23624214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between specific protein synthesis and tumoricidal function in murine peritoneal macrophages.
    Tannenbaum CS; Largen MT
    Cell Immunol; 1990 Nov; 131(1):52-66. PubMed ID: 2121374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages.
    Evans R; Eidlen DM
    J Natl Cancer Inst; 1983 Nov; 71(5):983-9. PubMed ID: 6580500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of afferent arc of the in vivo cytotoxic T-cell immunity by bacterial lipopolysaccharides.
    Mizoguchi K; Nakashima I; Hasegawa Y; Isobe K; Kato N; Shimokata K; Kawashima K; Nagase F; Ando K; Yoshida T
    Cell Immunol; 1985 Oct; 95(2):330-9. PubMed ID: 2931181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
    Okura A; Arakawa H; Yoshinari T; Naito K; Ishizuka M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Apr; 39(4):575-80. PubMed ID: 3458691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dimethyldioctadecylammonium bromide on phagocytosis and digestion of Listeria monocytogenes by mouse peritoneal macrophages.
    Hofhuis FM; Van der Meer C; Kersten MC; Rutten VP; Willers JM
    Immunology; 1981 Jul; 43(3):425-31. PubMed ID: 6788683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tumor-inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    J Immunol; 1985 Jul; 135(1):679-83. PubMed ID: 3839006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 279.